Life‐threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor
- 1 November 1987
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 39 (5) , 467-470
- https://doi.org/10.1111/j.1600-0609.1987.tb01458.x
Abstract
A 16-yr-old girl with severe von Willebrand disease complicated by the development of precipitating alloantibodies to von Willebrand factor (anti-VWF) had a life-threatening anaphylactoid reaction immediately after the infusion of a commercial plasma concentrate of factor VIII/von Willebrand factor. An early post-infusion activation of the complement system was demonstrated by the appearance of C3 split products and by the drop of serum CH50 activity, occurring in parallel with a post-infusion drop in the anti-VWF antibody levels. Immune complexes remained unchanged in the early post-infusion period and rose to a moderate extent only after 24 h. We conclude that biologically active products of the complement system contributed to the onset of this life-threatening reaction which occurred after concentrate infusion.Keywords
This publication has 5 references indexed in Scilit:
- Selective C3 deficiency due to C3 nephritic factor in an apparently healthy girlLa Ricerca in Clinica e in Laboratorio, 1985
- An enzyme-linked immunoassay for circulating immune complexes using solid phased goat C1qJournal of Immunological Methods, 1983
- Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapyBlood, 1981
- A familial dysfunction of the eighth component of complement (C8)Clinical Immunology and Immunopathology, 1980
- C1q: Rapid Purification Method for Preparation of Monospecific Antisera and for Biochemical StudiesThe Journal of Immunology, 1971